Evidence map›Paper›PMID 39480110›Full record

ArticleJournal of virology2024

Proteome profiling of polyomavirus nuclear replication centers using iPOND.

Kimberly D Erickson, Erika S Langsfeld, Alexandra Holland, Christopher C Ebmeier, Robert L Garcea

Abstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kimberly D EricksonThe BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.ORCID 0000-0002-6260-282X
Erika S LangsfeldThe BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.ORCID 0000-0002-4399-1911
Alexandra HollandThe BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Christopher C EbmeierDepartment of Biochemistry, University of Colorado Boulder, Boulder, Colorado, USA.
Robert L GarceaThe BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.ORCID 0000-0001-5109-6389

Funding

Mechanisms in Polyomavirus AssemblyR01AI151636 · NIAID · UNIVERSITY OF COLORADO · PI GARCEA, ROBERT L · 2020 to 2024
$1.9M
Opera Phenix High Throughput and High Content Confocal MicroscopeS10OD025072 · OD · UNIVERSITY OF COLORADO · PI LIU, XUEDONG · 2018 to 2018
$1.1M
HHS | National Institutes of Health (NIH) R01 AI151636-37NIAID NIH HHS R01 AI151636NIH HHS S10 OD025072
6 · The paper itself

Abstract

Polyomaviruses (PyVs) cause diverse diseases in a variety of mammalian hosts. During the life cycle, PyVs recruit nuclear host factors to viral genomes to facilitate replication and transcription. While host factors involved in DNA replication, DNA damage sensing and repair, and cell cycle regulation have been observed to bind PyV DNA, the complete set of viral and host proteins comprising the PyV replisome remains incompletely characterized. Here, the iPOND-MS technique (Isolation of Proteins on Nascent DNA coupled with Mass Spectrometry) was used to identify the proteome bound to murine PyV (MuPyV) DNA immediately following synthesis and 2 hours post-synthesis. Several novel MuPyV DNA interactors were identified on newly synthesized viral DNA (vDNA), including MCM complex members, DNA primase, DNA polymerase alpha, DNA ligase, and replication factor C. Though displaying partial overlap, the host and viral proteins bound to MuPyV DNA 2 hours post-synthesis lacked many of the replication proteins found on newly synthesized vDNA. These data help distinguish between the host factors critical for MuPyV DNA replication and those involved in downstream processing.IMPORTANCEPolyomaviruses are the causative agents of serious diseases in humans, including progressive multifocal leukoencephalopathy (PML), BK virus nephropathy, and Merkel cell carcinoma. The exact mechanisms by which the virus replicates, and which host cell proteins are required, are incompletely characterized. Identifying the host proteins necessary for efficient viral replication in the cell may reveal targets for downstream targets that may suppress viral replication

Indexed as

DNA ReplicationDNA, ViralPolyomavirusProteomeVirus ReplicationAnimalsHost-Pathogen InteractionsHumansMass SpectrometryMicePolyomavirus InfectionsProteomicsViral ProteinsDNA, ViralProteomeViral ProteinsDNA tumor virusiPONDpolyomavirusproteomicsviral replication

Identifiers

PMID39480110
PMCPMC11575236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.